NCT02462629 2023-02-21
Study of BLZ-100 in Pediatric Subjects With CNS Tumors
Blaze Bioscience Inc.
Phase 1 Completed
Clinical Trials
5 trialsNCT02496065 2017-07-13
Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery
Blaze Bioscience Inc.
Phase 1 Completed
NCT02464332 2016-05-26
Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery
Blaze Bioscience Inc.
Phase 1 Withdrawn
NCT02234297 2016-04-06
Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery
Blaze Bioscience Inc.
Phase 1 Completed
NCT02097875 2015-04-21
Safety Study of a Fluorescent Marker to Visualize Cancer Cells
Blaze Bioscience Australia Pty Ltd
Phase 1 Completed